D'ANTONGIOVANNI, VANESSA
 Distribuzione geografica
Continente #
NA - Nord America 3.487
AS - Asia 2.065
EU - Europa 1.739
SA - Sud America 312
AF - Africa 116
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.727
Nazione #
US - Stati Uniti d'America 3.387
IT - Italia 748
SG - Singapore 716
CN - Cina 535
HK - Hong Kong 293
BR - Brasile 252
DE - Germania 212
VN - Vietnam 173
SE - Svezia 167
FI - Finlandia 106
GB - Regno Unito 103
FR - Francia 82
BG - Bulgaria 67
JP - Giappone 61
CA - Canada 53
AT - Austria 52
IN - India 49
TR - Turchia 48
PL - Polonia 39
NL - Olanda 38
RU - Federazione Russa 38
CI - Costa d'Avorio 33
KR - Corea 32
MX - Messico 30
AR - Argentina 22
IQ - Iraq 22
IR - Iran 22
SN - Senegal 21
BD - Bangladesh 18
ZA - Sudafrica 16
CH - Svizzera 15
UA - Ucraina 15
UZ - Uzbekistan 15
PH - Filippine 13
PK - Pakistan 12
ES - Italia 11
MA - Marocco 11
EC - Ecuador 10
PT - Portogallo 10
SA - Arabia Saudita 10
VE - Venezuela 9
CZ - Repubblica Ceca 8
ID - Indonesia 8
NG - Nigeria 8
KE - Kenya 7
LT - Lituania 7
BE - Belgio 6
CO - Colombia 6
IE - Irlanda 5
JO - Giordania 5
MY - Malesia 5
AU - Australia 4
CL - Cile 4
DZ - Algeria 4
TN - Tunisia 4
TW - Taiwan 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
EG - Egitto 3
GH - Ghana 3
JM - Giamaica 3
NP - Nepal 3
PA - Panama 3
PY - Paraguay 3
AL - Albania 2
AM - Armenia 2
CR - Costa Rica 2
ET - Etiopia 2
GT - Guatemala 2
HN - Honduras 2
IL - Israele 2
KG - Kirghizistan 2
KZ - Kazakistan 2
NZ - Nuova Zelanda 2
PE - Perù 2
PS - Palestinian Territory 2
SV - El Salvador 2
UG - Uganda 2
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CU - Cuba 1
GD - Grenada 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
KI - Kiribati 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
MU - Mauritius 1
QA - Qatar 1
RS - Serbia 1
TJ - Tagikistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.727
Città #
Ashburn 436
Dallas 426
Singapore 401
San Jose 307
Hong Kong 280
Santa Clara 210
Chandler 175
Fairfield 164
Ann Arbor 161
Woodbridge 148
Shanghai 121
Milan 112
Serra 93
Los Angeles 92
New York 86
Pisa 82
Beijing 78
Boardman 76
Sofia 67
Munich 64
Wilmington 62
Seattle 61
Houston 59
London 55
Florence 49
Hefei 49
Tokyo 47
Ho Chi Minh City 46
Council Bluffs 39
Rome 38
Cambridge 37
Frankfurt am Main 37
Vienna 37
Lappeenranta 35
Abidjan 33
Hanoi 33
Lucca 33
Princeton 33
Helsinki 32
Lauterbourg 32
Turku 31
Seoul 30
Lawrence 29
Warsaw 28
São Paulo 27
Atlanta 25
Bremen 24
Boulder 23
Istanbul 22
Dakar 21
Montignoso 21
Dong Ket 20
Ottawa 19
Redondo Beach 19
Medford 18
Montreal 17
Ogden 17
Buffalo 16
Naples 15
Livorno 14
Des Moines 13
Nuremberg 13
Columbus 12
Marseille 12
Tashkent 12
Baghdad 11
Baltimore 11
Chicago 11
Orem 11
Zurich 11
Johannesburg 10
Brooklyn 9
Cascina 9
Chennai 9
Fuzhou 9
Phoenix 9
Poplar 9
San Diego 9
Toronto 9
Izmir 8
Kent 8
Ottaviano 8
Aguascalientes 7
Amsterdam 7
Brasília 7
City of London 7
Denver 7
Guangzhou 7
Manchester 7
Mumbai 7
Nairobi 7
Nanjing 7
Ankara 6
Belo Horizonte 6
Boston 6
Brno 6
Brussels 6
Changsha 6
Da Nang 6
Jacksonville 6
Totale 5.203
Nome #
Different patterns of H2S/NO activity and cross-talk in the control of the coronary vascular bed under normotensive or hypertensive conditions 296
Altered Protease-Activated Receptor-1 Expression and Signaling in a Malignant Pleural Mesothelioma Cell Line, NCI-H28, with Homozygous Deletion of the beta-Catenin Gene. 238
A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation 225
Colonic dysmotility associated with high-fat diet-induced obesity: Role of enteric glia 224
Prodromal Intestinal Events in Alzheimer's Disease (AD): Colonic Dysmotility and Inflammation Are Associated with Enteric AD-Related Protein Deposition 213
The activation of mitochondrial BK potassium channels contributes to the protective effects of naringenin against myocardial ischemia/reperfusion injury 207
Preclinical development of fa5, a novel amp-activated protein kinase (Ampk) activator as an innovative drug for the management of bowel inflammation 198
Dietary Supplementation with the Probiotic SF68 Reinforces Intestinal Epithelial Barrier in Obese Mice by Improving Butyrate Bioavailability 197
Retinal defects in mice lacking the autism-associated gene Engrailed-2 197
Putative biomarkers for malignant pleural mesothelioma suggested by proteomic analysis of cell line secretome 196
Dietary Supplement, Containing the Dry Extract of Curcumin, Emblica and Cassia, Counteracts Intestinal Inflammation and Enteric Dysmotility Associated with Obesity 194
NLRP3 at the crossroads between immune/inflammatory responses and enteric neuroplastic remodelling in a mouse model of diet-induced obesity 192
ROLE OF ENDOTHELIAL NO IN THE VASORELAXING EFFECTS INDUCED BY H2S IN CONDUCTANCE AND RESISTANCE RAT ARTERIES 188
Dysregulation of PAR1 expression and signaling in a mesothelioma cell line, NCI-H28, with homozygous deletion of the β-catenin gene. 183
Glial A2B Adenosine Receptors Modulate Abnormal Tachykininergic Responses and Prevent Enteric Inflammation Associated with High Fat Diet-Induced Obesity 183
VASORELAXING EFFECTS OF H2S IN RAT MESENTERIC ARTERIES 178
Donepezil improves vascular function in a mouse model of Alzheimer's disease 176
Use of Saccharomyces boulardii CNCM I-745 as therapeutic strategy for prevention of nonsteroidal anti-inflammatory drug-induced intestinal injury 175
Myriocin Effect on Tvrm4 Retina, an Autosomal Dominant Pattern of Retinitis Pigmentosa 169
Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson’s disease before brain pathology 169
Intestinal histomorphological and molecular alterations in patients with Parkinson's disease 166
Managing Obesity and Related Comorbidities: A Potential Pharmacological Target in the Adenosine System? 164
TGFβ upregulates PAR-1 expression and signalling responses in A549 lung adenocarcinoma cells 161
A Nutraceutical Strategy to Slowing Down the Progression of Cone Death in an Animal Model of Retinitis Pigmentosa 159
Enteric Glia and Brain Astroglia: Complex Communication in Health and Disease along the Gut-Brain Axis 154
The intestinal barrier in disorders of the central nervous system 153
Adenosine signaling in the tumor microenvironment 150
Primary fibroblast co-culture stimulates growth and metabolism in Sdhb-impaired mouse pheochromocytoma MTT cells 146
From the intestinal mucosal barrier to the enteric neuromuscular compartment: an integrated overview on the morphological changes in Parkinson's disease 144
Baseline Assessment of Serum Cytokines Predicts Clinical and Endoscopic Response to Ustekinumab in Patients With Crohn’s Disease: A Prospective Pilot Study 134
Serum oncostatin M predicts mucosal healing in patients with inflammatory bowel diseases treated with anti-TNF, but not vedolizumab 134
Evaluation of the beneficial effects of a GABA-based product containing Melissa officinalis on post-inflammatory irritable bowel syndrome: a preclinical study 131
Enteric glial NLRP3 inflammasome contributes to gut mucosal barrier alterations in a mouse model of diet-induced obesity 129
The pharmacological blockade of P2X4 receptor as a viable approach to manage visceral pain in a rat model of colitis 123
The microenvironment induces collective migration in SDHB-silenced mouse pheochromocytoma spheroids 123
Author Correction: Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson’s disease before brain pathology (npj Parkinson's Disease, (2022), 8, 1, (9), 10.1038/s41531-021-00263-x) 122
Intestinal epithelial barrier and neuromuscular compartment in health and disease 121
Lactiplantibacillus plantarum HEAL9 attenuates cognitive impairment and progression of Alzheimer's disease and related bowel symptoms in SAMP8 mice by modulating microbiota-gut-inflammasome-brain axis 120
null 114
Approaches for designing and discovering purinergic drugs for gastrointestinal diseases 113
Enteric glia at the crossroads between intestinal immune system and epithelial barrier: Implications for parkinson disease 111
Multivalent MMP-12 inhibitors as a valuable approach to counteract the intestinal epithelial barrier impairment and inflammation in an in vitro model mimicking intestinal high-fat exposure 110
INVOLVEMENT OF NO PATHWAY IN THE VASOACTIVE EFFECTS OF HYDROGEN SULPHIDE ON CONDUCTANCE AND RESISTANCE RAT BLOOD VESSELS 108
Pathological Remodeling of the Gut Barrier as a Prodromal Event of High-Fat Diet-Induced Obesity 105
null 103
Pharmacological modulation of P2X4 in inflammatory bowel diseases: the way towards novel therapeutics? 99
The adenosine system at the crossroads of intestinal inflammation and neoplasia 97
Palmitoylethanolamide Counteracts Enteric Inflammation and Bowel Motor Dysfunctions in a Mouse Model of Alzheimer’s Disease 95
Prolonged treatment with probiotics mitigates intestinal dysfunction and enteric Alzheimer's-related pathology in senescence-accelerated mice 93
α-Synuclein in Parkinson's Disease: From Bench to Bedside 87
The administration of Enterococcus faecium SF68 counteracts compositional shifts in the gut microbiota of diet-induced obese mice 75
Special Issue “Drugs in Inflammatory Bowel Diseases” 20
Gut Microbiota Manipulation by Probiotic Lacticaseibacillus paracasei DG I1572 as New Therapeutical Strategy to Counteract Vascular Inflammaging 17
Totale 7.879
Categoria #
all - tutte 22.813
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.813


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202170 0 0 0 0 0 0 0 0 0 0 22 48
2021/2022374 12 11 5 9 57 56 35 18 32 36 30 73
2022/2023732 67 116 48 65 50 73 7 74 151 23 48 10
2023/2024719 46 71 101 46 103 104 25 40 31 31 61 60
2024/20251.984 31 54 53 117 135 258 207 83 233 196 218 399
2025/20262.877 198 284 458 308 326 192 386 151 196 348 30 0
Totale 7.879